Jamie Daw
Jamie Daw
Columbia University Mailman School of Public Health
Verified email at columbia.edu - Homepage
Title
Cited by
Cited by
Year
Prescription drug use during pregnancy in developed countries: a systematic review
JR Daw, GE Hanley, DL Greyson, SG Morgan
Pharmacoepidemiology and drug safety 20 (9), 895-902, 2011
2562011
Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010
JR Daw, SG Morgan
Health Policy 104 (1), 19-26, 2012
1232012
Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001–2006)
JR Daw, B Mintzes, MR Law, GE Hanley, SG Morgan
Clinical therapeutics 34 (1), 239-249. e2, 2012
1132012
Matching and regression to the mean in difference‐in‐differences analysis
JR Daw, LA Hatfield
Health services research 53 (6), 4138-4156, 2018
1092018
Estimated cost of universal public coverage of prescription drugs in Canada
SG Morgan, M Law, JR Daw, L Abraham, D Martin
CMAJ 187 (7), 491-497, 2015
1052015
Women in the United States experience high rates of coverage ‘churn’in months before and after childbirth
JR Daw, LA Hatfield, K Swartz, BD Sommers
Health Affairs 36 (4), 598-606, 2017
1012017
Rethinking Pharmacare in Canada
SG Morgan, JR Daw, MR Law
CD Howe Institute, 2013
512013
The future of drug coverage in Canada
SG Morgan, D Martin, MA Gagnon, B Mintzes, JR Daw, J Lexchin
492015
Association of the Affordable Care Act dependent coverage provision with prenatal care use and birth outcomes
JR Daw, BD Sommers
Jama 319 (6), 579-587, 2018
402018
Growth in private payments for health care by Canadian households
MR Law, JR Daw, L Cheng, SG Morgan
Health Policy 110 (2-3), 141-146, 2013
382013
International best practices for negotiating ‘reimbursement contracts’ with price rebates from pharmaceutical companies
S Morgan, J Daw, P Thomson
Health Affairs 32 (4), 771-777, 2013
382013
Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada
JR Daw, SG Morgan, PA Thomson, MR Law
Health policy 110 (1), 67-75, 2013
362013
Canadian pharmacare: looking back, looking forward
SG Morgan, JR Daw
Healthcare Policy 8 (1), 14, 2012
332012
The Affordable Care Act and access to care for reproductive-aged and pregnant women in the United States, 2010–2016
JR Daw, BD Sommers
American journal of public health 109 (4), 565-571, 2019
302019
Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis
JH Puyat, JR Daw, CM Cunningham, MR Law, ST Wong, DL Greyson, ...
Social psychiatry and psychiatric epidemiology 48 (12), 1861-1872, 2013
262013
Preconception coverage before and after the Affordable Care Act Medicaid expansions
MA Clapp, KE James, AJ Kaimal, JR Daw
Obstetrics & Gynecology 132 (6), 1394-1400, 2018
232018
Matching in difference‐in‐differences: between a rock and a hard place
JR Daw, LA Hatfield
Health services research 53 (6), 4111, 2018
222018
Use of product listing agreements by Canadian provincial drug benefit plans
SG Morgan, MK Friesen, PA Thomson, JR Daw
Healthcare Policy 8 (4), 45, 2013
222013
Canadian policy makers’ views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers
SG Morgan, PA Thomson, JR Daw, MK Friesen
Health Policy 112 (3), 248-254, 2013
212013
Seeking safe stool: Canada needs a universal donor model
C Edelstein, JR Daw, Z Kassam
Cmaj 188 (17-18), E431-E432, 2016
202016
The system can't perform the operation now. Try again later.
Articles 1–20